Perspectives on Radiopharmaceutical Agents from the FDA: A Conversation between Lou Marzella, Johannes Czernin, and Thomas Hope
J Nucl Med
.
2021 Jul 1;62(7):881-883.
doi: 10.2967/jnumed.121.262450.
Authors
Lou Marzella
1
,
Johannes Czernin
2
,
Thomas Hope
3
Affiliations
1
Food and Drug Administration, Silver Spring, Maryland.
2
Department of Nuclear Medicine, UCLA School of Medicine, Los Angeles, California; and.
3
Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California.
PMID:
34244366
DOI:
10.2967/jnumed.121.262450
No abstract available
Publication types
Interview
MeSH terms
Drug Approval
Humans
Radiopharmaceuticals*
United States
United States Food and Drug Administration*
Substances
Radiopharmaceuticals